Apparatus and method for noninvasive monitoring of analytes in body fluids

• US 7,214,190 B1
• Filed: 09/09/2004
• Issued: 05/08/2007
• Est. Priority Date: 09/09/2003
• Status: Expired due to Fees

• Current Assignee: Kitchener Clark Wilson
• Original Assignee: Kitchener Clark Wilson
• Inventors: Wilson, Kitchener Clark
• Primary Examiner(s): Winakur; Eric
• Assistant Examiner(s): BERHANU, ETSUB D
• Application Number:
  US10/936,851
• Time in Patent Office: 971 Days
• Field of Search: 600/309, 600/310, 600/312, 600/317, 600/329
• US Class Current: 600/309
• CPC Class Codes: A61B 5/05 Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves impedance plethysmography A61B5/0295; measuring movement of the entire body or parts thereof A61B5/11; detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof A61B5/24
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/681 Wristwatch-type devices
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G01N 27/3271 Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood amperometry per se G01N27/49; aspects concerning the enzyme reagent C12Q1/001
• CPC Class Codes: G01R 33/46 NMR spectroscopy

Abstract

Noninvasive in vivo real time analyte measurement uses a multitude of sensors binding reversibly to the analyte whereby the response of the sensors to a noninvasive stimulus is altered by their bound versus unbound state. The stimulus and responses are electromagnetic, magnetic or any other suitable forms. The sensors are bound to a blood component providing transport through the body fluids and sensor elimination. A sensor is constructed from proteins or as a nanodevice. A noninvasive device generates the stimulus, senses the responses, determines the measurement, and controls a medication infusion pump. A non-contact device is used for population screening, and one form of such a device is a nuclear magnetic resonance imager. Measurement in fluids other than blood uses a blood component flowing out of blood and into the desired fluid.

Claims

1. An apparatus for measuring an analyte in the body fluids of a subject comprising:

a plurality of sensors that undergo a physical or chemical or electrical or optical change when bound to an analyte, each sensor responsive to said change and to at least one stimulating signal and responsively generating at least one reporting signal, each sensor adapted to bind to a body fluid transporter for transport through the subject body fluids and for elimination where the elimination rate of the transporter is known;

a stimulator generating the at least one stimulating signal;

at least one detector responsive to said plurality of reporting signals and responsively generating at least one detector signal; and

a processor configured to determine an analyte measurement in response to the at least one detector signal and the known transporter elimination rate,

whereby, said plurality of sensors is transported through the body fluids bound to a plurality of said transporters.

2. The apparatus according to claim 1, wherein each of said sensors comprises:

a reversible analyte binding site;

a signaling site responsive to the bound and unbound status of the analyte binding site and to said at least one stimulating signal and generating said at least one reporting signal accordingly; and

a binding site adapted to bind to said transporter.

3. The apparatus according to claim 2 wherein the binding characteristics of said analyte binding site are known and said analyte measurement is further responsive to the known binding characteristics.

4. The apparatus according to claim 1, wherein said at least one stimulating signal is taken from the electromagnetic spectrum.

5. The apparatus according to claim 1, wherein at least one stimulating signal is magnetic.

6. The apparatus according to claim 1, wherein said at least one reporting signal is fluorescence.

7. The apparatus according to claim 1, wherein at least one reporting signal is within the radio frequency spectrum.

8. The apparatus according to claim 1, wherein said body fluid transporter comprises an endogenous blood component.

9. The apparatus according to claim 1, wherein said at least one stimulating signal is generated by a nuclear magnetic resonance imaging device, and said at least one detector and said processor are components of the nuclear magnetic resonance imaging device.

10. The apparatus according to claim 9, wherein said measurement comprises the location of said at least one reporting signal within the subject.

11. A method for measuring an analyte in the body fluids of a subject comprising the steps of:

administering a plurality of sensors into the subject body fluids, each of said sensors comprising;

a reversible analyte binding site;

a signaling site responsive to the bound and unbound status of the analyte binding site and to at least one external stimulating signal and responsively generating at least one reporting signal; and

a binding site to a body fluid transporter, said transporter providing sensor transport through the body fluids and elimination where the elimination rate of said transporter is known;

providing the at least one stimulating signal;

generating at least one detector signal in response to said reporting signals;

determining the analyte measurement in response to the at least one detector signal and the known transporter elimination rate; and

outputting the analyte measurement.

12. The method according to claim 11, wherein the binding characteristics of said analyte binding site are known and said analyte measurement is further responsive to the known binding characteristics.

13. The method according to claim 11, wherein said body fluid transporter comprises an endogenous blood component.

14. The method according to claim 11 including the step of binding said transporter to said sensor prior to sensor administration into said body fluids.